Indecainide

Chemical compound
  • none
Identifiers
  • 9-[3-(isopropylamino)propyl]-9H-fluorene-9-carboxamide
CAS Number
  • 74517-78-5 checkY
    73681-12-6 (HCl)
PubChem CID
  • 52194
DrugBank
  • DB00192 checkY
ChemSpider
  • 47194 checkY
UNII
  • 3AZF20DM1T
KEGG
  • D04521 checkY
ChEMBL
  • ChEMBL1201242 ☒N
CompTox Dashboard (EPA)
  • DTXSID2057819 Edit this at Wikidata
Chemical and physical dataFormulaC20H24N2OMolar mass308.425 g·mol−13D model (JSmol)
  • Interactive image
  • O=C(N)C3(c1ccccc1c2c3cccc2)CCCNC(C)C
InChI
  • InChI=1S/C20H24N2O/c1-14(2)22-13-7-12-20(19(21)23)17-10-5-3-8-15(17)16-9-4-6-11-18(16)20/h3-6,8-11,14,22H,7,12-13H2,1-2H3,(H2,21,23) checkY
  • Key:UCEWGESNIULAGX-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Indecainide (INN, trade name Decabid) is a class Ic antiarrhythmic agent.[1] Developed and marketed by Lilly, it has now been discontinued.

References

  1. ^ Jaillon P, Drici M (December 1989). "Recent antiarrhythmic drugs". The American Journal of Cardiology. 64 (20): 65J–69J. doi:10.1016/0002-9149(89)91203-4. PMID 2688391.

External links

  • FDA drug details [1]
  • v
  • t
  • e
Antiarrhythmic agents (C01B)
Channel blockers
class I
(Na+ channel blockers)
class Ia (Phase 0→ and Phase 3→)
class Ib (Phase 3←)
class Ic (Phase 0→)
class III
(Phase 3→, K+ channel blockers)
class IV
(Phase 4→, Ca2+ channel blockers)
Receptor agonists
and antagonists
class II
(Phase 4→, β blockers)
A1 agonist
M2
α receptors
Ion transporters
Na+/ K+-ATPase


Stub icon

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e